GlassScriptPhysician profile
David P Trofa
NPI 1003159328
$33,207.51
in general payments reported to CMS, 2019-2025
9 companies · $282 in 2025
The $282 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $3,825 · 2021: $2,827 · 2022: $3,038 · 2023: $1,551 · 2024: $5,833 · 2025: $282.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,500 · Travel and Lodging: $1,529 · Food and Beverage: $638.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,500.00 |
| Travel and Lodging | $1,528.58 |
| Food and Beverage | $637.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $8,889.15 | 2019-2025 | |
| Gotham Surgical Solutions & Devices, INC. | $8,664.63 | 2019-2025 | |
| Vericel Corporation | $5,761.93 | 2019-2024 | Maci |
| Peerless Surgical INC. | $4,987.17 | 2019-2023 | |
| Smith+Nephew, INC. | $4,203.07 | 2019-2025 | Acufex Meniscal Root Repair |
| Stryker Corporation | $590.63 | 2019-2024 | Alphavent, Variax |
| Miach Orthopaedics, INC. | $94.24 | 2021 | |
| Kci USA, INC. | $16.69 | 2023 | V.A.C.Ulta, V.A.C. Veraflo, Prevena |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Trofa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.